Nestle CEO sees weight-loss drugs lifting vitamin sales

Nestle SA Chief Executive Officer Mark Schneider said the company’s nutritional products will benefit from a boom in weight-loss drugs, as consumers turn to offerings like Orgain protein shakes and Solgar vitamins. The success of medicines known as GLP-1s for obesity has rippled beyond the pharmaceutical market, raising worries among investors that their effect on users’ appetites will curb demand for products like KitKat wafers.